GlassScriptPhysician profile
Richard S Eubanks
NPI 1518995521
$14,191.63
in general payments reported to CMS, 2019-2025
26 companies · $6,039 in 2025
The $6,039 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $175 · 2021: $622 · 2022: $2,152 · 2023: $1,469 · 2024: $3,164 · 2025: $6,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,250 · Food and Beverage: $3,623 · Travel and Lodging: $1,799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,250.00 |
| Food and Beverage | $3,622.63 |
| Travel and Lodging | $1,799.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,415.24 | 2022-2025 | Da Vinci Surgical System |
| Abiomed | $1,858.65 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $1,019.26 | 2021-2025 | Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $700.06 | 2019-2023 | Gore Tag Thoracic Endoprosthesis |
| Elutia, INC. | $657.33 | 2019-2023 | |
| Endologix LLC | $436.89 | 2019-2021 | |
| Medela LLC | $436.02 | 2025 | |
| Medtronic, INC. | $322.87 | 2022-2025 | Endurant Iis, Corevalve Evolut R |
| Baxter Healthcare | $248.54 | 2021-2022 | |
| Accord Healthcare, INC. | $241.16 | 2025 | |
| Corcym INC | $112.57 | 2024 | Perceval |
| Atricure, INC. | $111.12 | 2022-2024 | |
| Abbott Laboratories | $99.34 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $87.38 | 2021 | |
| Philips North America LLC | $85.02 | 2025 | Azurion 7 M20 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $82.99 | 2019 | |
| Medtronic Vascular, INC. | $57.31 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.90 | 2021 | |
| Chiesi USA, INC. | $34.25 | 2019-2021 | |
| Kci USA, INC. | $24.82 | 2022 | |
| Penumbra, INC. | $22.45 | 2021 | |
| Ethicon INC. | $21.90 | 2021 | |
| Smith+Nephew, INC. | $20.41 | 2019 | |
| Ethicon US, LLC | $16.15 | 2019 | |
| Lemaitre Vascular, INC. | $15.93 | 2019 | |
| Veran Medical Technologies, INC. | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.